Designed to enable constructive and functional tissue remodeling1
Phasix™ Mesh provides a fully resorbable monofilament scaffold for rapid tissue incorporation that has been designed to allow for the repair strength of a synthetic mesh along with the remodeling characteristics of a biologic graft.1 With rapid tissue ingrowth and long-lasting strength, Phasix™Mesh provides a strong, reliable repair when patients need it most.
1. Preclinical data on file. Results may not correlate to clinical performance in humans.
2. Deeken CR, Abdo MS, Frisella MM, Matthews BD. “Physicomechanical evaluation of absorbable and nonabsorbable barrier composite meshes for laparoscopic ventral hernia repair.” Surgical Endoscopy 25.5 (2010): 1541-552.
3. Estimated from Standard Curve in (Martin DP, et al. “Characterizationof poly-4-hydroxybutyrate mesh for hernia repair applications.” Journal of Surgical Research. 2013; (184): 766-773
4. Martin, DP. et al. “ Medical applications of poly-4-hydroxybutyrate:a strong flexible absorbable biomaterial. Biochemical Engineering Journal. 2002; December 9
5. Amid PK, Shulman AG, Lichtenstein IL, Hakaha M. Biomaterials for Abdominal Wall Hernia Surgery and Principles of their Applications. Langenbecks Archive Chir. 1994; 379(3): 168-71.
6. Halaweish I, Harth K, Broome AM, Voskerician G, Jacobs MR, Rosen M. Novel In Vitro Model for Assessing Susceptibility of Synthetic Hernia Repair Meshes to Staphylococcus aureus Infection Using Green Fluorescent Protein-Labeled Bacteria and Modern Imaging Techniques. J Surg Infect (Larchmt). 2010; Oct1(5): 449-54.
Indications
Phasix™ Mesh is indicated to reinforce soft tissue where weakness exists in patients undergoing plastic and reconstructive surgery, or for use in procedures involving soft tissue repair, such as the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Contraindications
Because Phasix™ Mesh is fully resorbable, it should not be used in repairs where permanent wound or organ support from the mesh is required.
Warnings
Phasix™ Mesh must not be put in direct contact with bowel or viscera. The safety and product use for patients with hypersensitivities to tetracycline hydrochloride or kanamycin sulfate is unknown. Use of this device in patients with known allergies to these antibiotics should be avoided. The safety and effectiveness of Phasix™ Mesh in pediatric use has not been evaluated or established. If an infection develops, treat the infection aggressively. An unresolved infection may require removal of the device.
Adverse Reactions
Possible complications include infection, seroma, pain, mesh migration, wound dehiscence, hemorrhage, adhesions, hematoma, inflammation, allergic reaction, extrusion, erosion, fistula formation and recurrence of the hernia or soft tissue defect.
Please consult package insert for more detailed safety information and instructions for use.
GTIN - Case
00801741107542
1
Quantity
1/cs.
Dimensions
3" x 6.3" Rectangle (8 x 16 cm)
| GTIN - Case | 00801741107542 | 1 |
| Quantity | 1/cs. |
| Dimensions | 3" x 6.3" Rectangle (8 x 16 cm) |
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Phasix™ Mesh provides a fully resorbable monofilament scaffold for rapid tissue incorporation that has been designed to allow for the repair strength of a synthetic mesh along with the remodeling characteristics of a biologic graft.
Composed of biologically-derived material, Poly-4-hydroxybutyrate (P4HB), Phasix™ Mesh provides critical strength during the initial healing phase with rapid tissue ingrowth and vascularization through its open-pore monofilament structure. Monomer form (4HB) is a naturally occurring human metabolite found in the brain, heart, liver, kidney, and muscle and P4HB scaffold has been used clinically for hernia repair for more than 5 years.
Phasix™ Mesh gradually and predictably degrades within 12 to 18 months via hydrolysis leaving behind a durable, functional repair with over 3x the strength of the native abdominal wall.
Phasix™ Mesh has not been shown to break down in the presence of bacteria - maintaining 100% of its strength at 56 days - unlike biologic grafts which demonstrate accelerated degradation in the presence of bacteria. Additionally, Phasix™ Mesh offers the benefits of rapid tissue incorporation with organized and functional collagen at the repair site, while offering high repair strength through the critical healing phase.
Phasix™ ST Mesh combines two market-leading technologies into one product: monofilament resorbable Phasix™ Mesh and a proven hydrogel barrier based on Sepra® technology. It handles, sutures and fixates like a synthetic mesh, while facilitating trocar deployment during laparoscopic placement.
Phasix™ ST Mesh combines Phasix™ Mesh and a proven hydrogel barrier based on Sepra® technology into one product. While the monofilament mesh supports functional healing and a strong repair, the hydrogel barrier is designed to minimize tissue attachment to the visceral side of the mesh for intraabdominal placement.
Phasix™ ST Mesh is a biologically derived scaffold with a hydrogel barrier for intraabdominal placement. It has been designed to provide the repair strength of a synthetic mesh and the remodeling characteristics of a biologic. Additionally, its longitudinal stripes aid with orientation and visibility during placement.
The ST hydrogel barrier is designed to minimize the risk of tissue attachment, resorbs within 30 days, and has over 10 years of clinical application.
Phasix™ Mesh comes in the following sizes:
Phasix™ Mesh comes in the following sizes:
More than 10 clinical studies with more than 950 patients studied
Phasix Clinical Compendium
For more information, please contact your local sales rep to learn more
2. Internal market research, data on file, 2015.
3. Liang MK, Li LT, Nguyen MT, Berger RL, Hicks SC, Kao LS. Abdominal reoperation and mesh explantation following open ventral hernia repair with mesh. The American Journal of Surgery. 208.4(2014):670–76.
4. Itani KM, et al. Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH Study. Surgery. 2012;152(3):498–505.
5. Annor AH, Tang ME, Pui CL, Ebersole GC, Frisella MM, Matthews BD, Deeken CR. Effect of enzymatic degradation on the mechanical properties of biological scaffold materials. Surgical Endoscopy. 26.10(2012):2767–778. 6. Harth KC, et al. Effect of surgical wound classification on biologic graft performance in complex hernia repair: an experimental study. Surgery. 2013;153(4):481–492
BD-46830
XenMatrix™ AB Surgical Graft, Square, 2.4 in x 2.4 in (6 cm x 6 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 2.4 in x 3.1 in (6 cm x 8 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 3.9 in x 2.4 in (6 cm x 10 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 6.3 in x 2.4 in (6 cm x 16 cm)
XenMatrix™ AB Surgical Graft, Square, 3.1 in x 3.1 in (8cm x 8cm)
XenMatrix™ AB Surgical Graft, Rectangle, 3.1 in x 6.3 in (8 cm x 16 cm)
XenMatrix™ AB Surgical Graft, Square, 3.9 in x 3.9 in (10 cm x 10 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 3.9 in x 5.9 in (10 cm x 15 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 3.9 in x 7.9 in (10 cm x 20 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 3.9 in x 11 in (10 cm x 28 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 5.9 in x 7.9 in (15 cm x 20 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 5.9 in x 9.8 in (15 cm x 25 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 5.9 in x 11.8 in (15 cm x 30 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 7.5 in x 11 in (19 cm x 28 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 7.5 in x 13.8 in (19 cm x 35 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 7.9 in x 7.9 in (20 cm x 20 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 7.9 in x 9.8 in (20 cm x 25 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 7.9 in x 15.7 in (20 cm x 40 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 9.8 in x 11.8 in (25 cm x30 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 9.8 in x 15.7 in (25 cm x 40 cm)
XenMatrix™ AB Surgical Graft, Square, 11.8 in x 11.8 in (30 cm x 30 cm)
XenMatrix™ AB Surgical Graft, Rectangle, 11.8 in x 17.7 in (30 cm x 45 cm)
Phasix™ ST Mesh, Round, 8 cm (3 in)
Phasix™ ST Mesh, Round, 11 cm (4.5 in)
Phasix™ ST Mesh, Round, 15 cm (6 in)
Phasix™ ST Mesh, Rectangle, 7 cm x 10 cm (3 in x 4 in)
Phasix™ ST Mesh, Square, 10 cm x 10 cm (4 in x 4 in)
Phasix™ ST Mesh, Rectangle, 10 cm x 15 cm (4 in x 6 in)
Phasix™ ST Mesh, Rectangle, 10 cm x 20 cm (4 in x 8 in)
Phasix™ ST Mesh, Rectangle, 13 cm x 25 cm (5 in x 10 in)
Phasix™ ST Mesh, Rectangle, 15 cm x 20 cm (6 in x 8 in)
Phasix™ ST Mesh, Rectangle, 20 cm x 25 cm (8 in x 10 in)
Phasix™ ST Mesh, Rectangle, 25 cm x 30 cm (10 in x 12 in)
Phasix™ ST Mesh, Rectangle, 30 cm x 35 cm (12 in x 14 in)
If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.
To better facilitate our investigation, please include the following information in your reporting:
